Clinical Trial Update: To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the effect of rosiglitazone and ramipril on pre-clinical vasculopathy in patients with diabetes and impaired glucose toleran…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Impaired Glucose Tolerance

Drugs mentioned

• Ramipril (ramipril)
• Rosiglitazone (rosiglitazone)

Snippet

Sponsor: Universiti Sains Malaysia | Conditions: Diabetes, Impaired Glucose Tolerance | Phase 3 | Status: COMPLETED